Found: 23
Select item for more details and to access through your institution.
Long‐term outcome of patients receiving haematopoietic allogeneic stem cell transplantation as first transplant for high‐risk Hodgkin lymphoma: a retrospective analysis from the Lymphoma Working Party‐EBMT.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 1018, doi. 10.1111/bjh.17939
- By:
- Publication type:
- Article
Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndrome.
- Published in:
- Bone Marrow Transplantation, 2014, v. 49, n. 11, p. 1360, doi. 10.1038/bmt.2014.161
- By:
- Publication type:
- Article
The outcome of reduced intensity allogeneic stem cell transplantation and autologous stem cell transplantation when performed as a first transplant strategy in relapsed follicular lymphoma: an analysis from the Lymphoma Working Party of the EBMT.
- Published in:
- Bone Marrow Transplantation, 2013, v. 48, n. 11, p. 1409, doi. 10.1038/bmt.2013.83
- By:
- Publication type:
- Article
Successful treatment of isolated cutaneous relapse of follicular lymphoma with rituximab.
- Published in:
- 2001
- By:
- Publication type:
- journal article
British HIV Association guidelines for HIV-associated malignancies 2008.
- Published in:
- HIV Medicine, 2008, v. 9, n. 6, p. 336, doi. 10.1111/j.1468-1293.2008.00608.x
- By:
- Publication type:
- Article
EZH2 Y641 mutations in follicular lymphoma.
- Published in:
- 2011
- By:
- Publication type:
- Letter
The role of in vivo T-cell depletion on reduced-intensity conditioning allogeneic stem cell transplantation from HLA-identical siblings in patients with follicular lymphoma.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Long-term follow-up of high-dose treatment with autologous haematopoietic progenitor cell support in 693 patients with follicular lymphoma: an EBMT registry study.
- Published in:
- Leukemia (08876924), 2007, v. 21, n. 11, p. 2324, doi. 10.1038/sj.leu.2404850
- By:
- Publication type:
- Article
Long term outcome of Peripheral T Cell Lymphomas: 10y follow‐up analysis of the International Prospective T Cell Project Network.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 491, doi. 10.1002/hon.3164_360
- By:
- Publication type:
- Article
PRIMARY EXTRANODAL FOLLICULAR LYMPHOMA IN A LARGE RETROSPECTIVE SURVEY OF THE INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP (IELSG31)
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.78_2879
- By:
- Publication type:
- Article
ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR PERIPHERAL T‐CELL LYMPHOMA: COMPARABLE OUTCOMES OF HAPLO‐IDENTICAL VS. MATCHED DONORS. A CIBMTR & EBMT ANALYSIS.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.53_2879
- By:
- Publication type:
- Article
THE EFFICACY OF IBRUTINIB IN PATIENTS WITH RELAPSED MANTLE CELL LYMPHOMA AFTER FIRST LINE INTENSIVE CHEMO‐IMMUNOTHERAPY AND ASCT – A RETROSPECTIVE STUDY FROM THE LWP‐EBMT.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 243, doi. 10.1002/hon.53_2630
- By:
- Publication type:
- Article
THE EFFICACY OF IBRUTINIB IN PATIENTS WITH RELAPSED MANTLE CELL LYMPHOMA AFTER FIRST LINE INTENSIVE CHEMO‐IMMUNOTHERAPY AND ASCT – A RETROSPECTIVE STUDY FROM THE LWP‐EBMT.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 243, doi. 10.1002/hon.53_2630
- By:
- Publication type:
- Article
APPLICATION OF CELL-OF-ORIGIN SUBTYPES DETERMINED BY DIGITAL GENE EXPRESSION IN HIV-RELATED DIFFUSE LARGE B-CELL LYMPHOMAS.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 156, doi. 10.1002/hon.2438_11
- By:
- Publication type:
- Article
THE RISK OF TRANSFORMATION OF FOLLICULAR LYMPHOMA 'TRANSFORMED' BY RITUXIMAB: THE ARISTOTLE STUDY PROMOTED BY THE EUROPEAN LYMPHOMA INSTITUTE.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 115, doi. 10.1002/hon.2437_104
- By:
- Publication type:
- Article
THE ROLE OF 18F FDG-PET/CT IN PERIPHERAL T-CELL LYMPHOMA (PTCL): INITIAL RESULTS OF THE UK NCRI MULTICENTRE PHASE II RANDOMISED CHEMO-T TRIAL PET/CT SUBSTUDY.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 244, doi. 10.1002/hon.2438_108
- By:
- Publication type:
- Article
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (ALLO-HSCT) FOR PATIENTS WITH RELAPSED/REFRACTORY SYSTEMIC ANAPLASTIC LARGE CELL LYMPHOMA (R/R SALCL). A RETROSPECTIVE ANALYSIS OF THE LYMPHOMA WORKING PARTY-EBMT.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 242, doi. 10.1002/hon.2438_106
- By:
- Publication type:
- Article
CHOP VERSUS GEM-P IN THE FIRST-LINE TREATMENT OF T-CELL LYMPHOMA (PTCL): INITIAL RESULTS OF THE UK NRCI PHASE II RANDOMISED CHEMO-T TRIAL.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 75, doi. 10.1002/hon.2437_63
- By:
- Publication type:
- Article
IMPROVED SURVIVAL OUTCOMES FOR PATIENTS WITH EXTRA-NODAL NK/T LYMPHOMA: DATA FROM 140 PATIENTS PROSPECTIVELY REGISTERED IN THE INTERNATIONAL T-CELL PROJECT.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 78, doi. 10.1002/hon.2437_66
- By:
- Publication type:
- Article
DURABLE BENEFIT OF RITUXIMAB MAINTENANCE POST-AUTOGRAFT IN PATIENTS WITH RELAPSED FOLLICULAR LYMPHOMA: 12-YEAR FOLLOW-UP OF THE EBMT LYMPHOMA WORKING PARTY LYM1 TRIAL.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 32, doi. 10.1002/hon.2437_13
- By:
- Publication type:
- Article
Human immunodeficiency virus-associated plasmablastic lymphoma: Poor prognosis in the era of highly active antiretroviral therapy.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Smoldering multiple myeloma: natural history and recognition of an evolving type.
- Published in:
- British Journal of Haematology, 2003, v. 123, n. 4, p. 631, doi. 10.1046/j.1365-2141.2003.04654.x
- By:
- Publication type:
- Article
Brentuximab vedotin in multifocal cutaneous anaplastic large cell lymphoma in a patient with human immunodeficiency virus following Hodgkin lymphoma.
- Published in:
- Clinical & Experimental Dermatology, 2019, v. 44, n. 5, p. 562, doi. 10.1111/ced.13824
- By:
- Publication type:
- Article